BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for March 22, 2023

March 22, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Debiopharm, HealthTech Connex, Helius Medical, Inspira, Starlight.
Read More

In the clinic for March 22, 2023

March 22, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edap Tms, Natera, Procyrion.
Read More

Financings for March 22, 2023

March 22, 2023
Med-tech firms raising money in public or private financings, including: Biomérieux, Lifemd, Proxim Diagnostics, Sotera Health.
Read More

Appointments and advancements for March 22, 2023

March 22, 2023
New hires and promotions in the med-tech industry, including: Diagnamed, Infinity Labs, Minerva Surgical, Presidio Medical.
Read More

Other news to note for March 22, 2023

March 22, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Almirall, Andira, CASI, Deerfield, Invitae, Inbox, Jacobio, Joincare, Landos, Medexus, Merck & Co., Nimmune, Peptidream, Polichem, Quince, Rakovina, Rayzebio, RQ, Sino, Taigen, Takeda, TC.
Read More

In the clinic for March 22, 2023

March 22, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Capstan, Durect, Generate, Nymox, Remix, Vaxess.
Read More

Financings for March 22, 2023

March 22, 2023
Biopharmas raising money in public or private financings, including: Acer, Alligator, Epibiologics, Hemostemix, Karuna.
Read More

Appointments and advancements for March 22, 2023

March 22, 2023
New hires and promotions in the biopharma industry, including: Capstan, Durect, Generate, Nymox, Remix, Vaxess.
Read More

Regulatory actions for March 14-20, 2023

March 21, 2023
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abbisko, Biontech, Everest Medicines, Glenmark, Kuria, Likang, Pfizer, Skye.
Read More

In the clinic for March 14-20, 2023

March 21, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alphamab Oncology, Alterity, Asahi Kasei, Astellas, Atea, Biothera Solutions, Boan, Canbridge, Direct Biologics, Hanmi, Immutep, Invex, Luye, Mabwell, Olipass, Pfizer, Telix, Vectivbio.
Read More
Previous 1 2 … 842 843 844 845 846 847 848 849 850 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing